EXOZYMES INC. — Director's Dealing 2024

Nov 19, 2024

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Invizyne Technologies Inc (IZTC)
CIK: 0002010788
Period of Report: 2024-11-08

Reporting Person: Nawaz Fouad (Vice President, Finance)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options for Common Stock	$3.31	2030-10-30	Common Stock (41552)		Direct
Stock Options for Common Stock	$8.00	2031-03-31	Common Stock (20776)		Direct

Footnotes

F1: The options vest as follows: The first 8,316 shares vest on September 1, 2025, and the balance vest at the rate of 2,079 shares per quarter, commencing on December 1, 2025, and become exercisable once vested.

F2: The options vest as follows: The first 4,152 shares vest on April 1, 2025, then at the rate of 1,038 shares per quarter, commencing on July 1, 2025, and then the balance shall vest on the five-year anniversary of the Date of Grant, and become exercisable once vested.